Literature DB >> 29907228

Diagnostic inflammatory markers in acute cholangitis.

Andrei M Beliaev1, Michael Booth2, David Rowbotham3, Colleen Bergin4.   

Abstract

BACKGROUND: The 2018 Tokyo guidelines for acute cholangitis (AC) use white cell count (WCC) as one of the diagnostic criteria. However, the 2018 Tokyo guidelines grading does not provide guidance for AC patients with normal WCC. In this situation, other inflammatory biomarkers also can be used to diagnose AC and grade severity, but their diagnostic values are yet undetermined. The aims of this study were to evaluate the discriminative powers of common inflammatory markers compared with WCC for diagnosing AC and to determine their diagnostic cutoff levels.
METHODS: This was a retrospective cohort study. Over 2 y, 96 patients who underwent endoscopic biliary decompression were identified from the Auckland City Hospital Radiology Department database. Only patients with a confirmed diagnosis of AC were included in the study. Thirty-four patients with AC and 18 controls met eligibility criteria.
RESULTS: Comparing areas under the receiver operating characteristic curves, it was the lymphocyte count, neutrophil-to-lymphocyte ratio (NLR), and C-reactive protein (CRP) that had the highest discriminative powers in diagnosing AC. Values of WCC for diagnosing AC were equal to or above 9.6 × 109/L, neutrophil count equal to or exceeding 4.9 × 109/L, lymphocyte count equal to or below 1.3 × 109/L, NLR 5.3 and above, albumin equal to or below 30.5 g/L, and CRP concentration 23.5 mg/L or above.
CONCLUSIONS: Lymphocyte count, NLR, and CRP have superior discriminative powers to WCC, albumin, and neutrophil count and can be useful in the diagnosis of AC.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute cholangitis; Diagnosis; Inflammatory biomarkers

Mesh:

Substances:

Year:  2018        PMID: 29907228     DOI: 10.1016/j.jss.2018.02.048

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Should lactate be added to Tokyo criteria for the evaluation of patients with acute cholangitis?

Authors:  Erdinc Gulumsek; Fatih Yesildal; Ismail Yigitdol; İbrahim Erdem; Huseyin Can Arbag; Akkan Avci; Tayyibe Saler; Banu Kara; Adnan Tas; Hilmi Erdem Sumbul
Journal:  Ir J Med Sci       Date:  2022-02-08       Impact factor: 1.568

2.  Dynamic Monitoring of sTREM-1 and Other Biomarkers in Acute Cholangitis.

Authors:  Jiahui Jiang; Xiaolei Wang; Tongtong Cheng; Mingyue Han; Xinxin Wu; Haitong Wan
Journal:  Mediators Inflamm       Date:  2020-05-15       Impact factor: 4.711

3.  Diagnostic Inflammation Biomarkers for Prediction of 30-Day Mortality Rate in Acute Cholangitis.

Authors:  Omer Al-Yahri; Raed M Al-Zoubi; Azza Alam Elhuda; Amina Ahmad; Mahmood Al Dhaheri; Sherif Abdelaziem; Mustafa Alwani; Ahmad R Al-Qudimat; Ahmad Zarour
Journal:  Int J Surg Protoc       Date:  2022-03-02

4.  Clinical Significance of the Neutrophil-Lymphocyte Ratio as an Early Predictive Marker for Adverse Outcomes in Patients with Acute Cholangitis.

Authors:  Sang-Hoon Lee; Tae-Yoon Lee; Jong-Hyeon Jeong; Young-Koog Cheon
Journal:  Medicina (Kaunas)       Date:  2022-02-09       Impact factor: 2.430

5.  Deep Learning-Based Method of Diagnosing Hyperlipidemia and Providing Diagnostic Markers Automatically.

Authors:  Yuliang Liu; Quan Zhang; Geng Zhao; Guohua Liu; Zhiang Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-11       Impact factor: 3.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.